Home
MRD as a monitoring technique of alloSCT and CAR-T in AML/ALL
VJHemOnc – Video Journal of Hematology & HemOnc
29 เม.ย. 2024
การดู 59 ครั้ง
Can ruxolitinib replace hydroxyurea as a frontline therapy for PV?
Treating Persistent/Chronic ITP Current Care, Future Potential
Orthopaedics in Oxford
Reigniting Hope to Reclaim Movement
ครั้งแรกของ 4 พี่น้องบ้าน ‘สุโกศล’ จะมาเล่าวิธีทำธุรกิจโรงแรม The Siam | Family Business Forum 2024
What is chronic lymphocytic leukaemia?
HRQoL, diagnosis and treatment experiences of patients with AL amyloidosis: a survey by MPE
Precision medicine and Oxford, challenges and opportunities - Sir John Bell GBE
What are the key diagnostic criteria for confirming MGUS?
Selecting therapeutics for treating early relapses in multiple myeloma
Prophylactic tocilizumab to mitigate CRS: results from a small cohort in the MajesTEC-1 trial
What are the side effects of immunotherapy?
MPE/ALAN Webinar | EU HTA
New hope for patients with incurable and disabling Dupuytren’s disease
How do we know that bacteria were around billions of years ago?
Studying Bloom Syndrome
Combining pembrolizumab with BCR inhibitors for Richter's transformation
Martin Landray: Big Data
Immunotherapy and breast cancer: how does it work?
The potential role of machine learning in amyloidosis